| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-301
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-5537 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-553
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-572
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate |
1989-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1992-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
1992-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0356128-B1 |
| titleOfInvention |
3-(aminopropyl)methyl phosphinic acid as a therapeutic agent |
| abstract |
The use of 3-(aminopropyl)methyl phosphinic acid as a potent selective GABAB receptor agonist, pharmaceutical compositions containing it, and its use in therapy, in particular in the treatment of central nervous system disorders. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7745474-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7812026-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7678808-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7718686-B2 |
| priorityDate |
1988-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |